DXM + Selegiline, rasagiline, and safinamide, with maintained MAO-B selectivity

No PHI rating

https://dxm-atlas.org/en/interactions/selegiline-rasagiline-safinamide-selectivity-maintained/

Compare

Why is there no PHI rating?

Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44].

Full explanation from the review

Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44]. Datura and Atropa belladonna are excluded because variable alkaloid concentrations undermine the known-exposure assumption [35]. Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31]. Their concerns are discussed in Sections 5 and 8.

General concepts in this text

MAO-B

A form of the MAO enzyme involved in breaking down some chemical messengers in the monoamine group.

MAO-A and MAO-B are two different forms of monoamine oxidase. The letter B identifies the enzyme form.

Sources: MAO-B

How to read ratings and study limits

MAO-B selectivity

Preferential inhibition of the MAO-B form of the enzyme compared with MAO-A.

MAO-A and MAO-B are two forms of monoamine oxidase. Loss of selectivity means more pronounced inhibition of MAO-A.

Sources: MAO-B selectivity

In the glossary

Sources

Scientific review: MAOIs and MDMA

Related entries

Reference

Open the source and related combinations →